Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Aliagas

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|February 14, 2013
Physicochemical and DMPK in silico models: facilitating their use by medicinal chemistsDaniel F Ortwine, Ignacio Aliagas
ACS Medicinal Chemistry Letters|June 26, 2018
Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-lifeFabio Broccatelli, Ignacio Aliagas, Hao Zheng
Drug Metabolism Letters|August 3, 2018
Using LC Retention Times in Organic Structure Determination: Drug Metabolite IdentificationWilliam L Fitch, Cyrus Khojasteh, Ignacio Aliagas, et al.
Journal of Computer-Aided Molecular Design|April 1, 2022
Comparison of logP and logD correction models trained with public and proprietary data setsIgnacio Aliagas, Alberto Gobbi, Man-Ling Lee, et al.
Journal of Chemical Information and Modeling|November 15, 2011
DEGAS: sharing and tracking target compound ideas with external collaboratorsMan-Ling Lee, Ignacio Aliagas, Jennafer Dotson, et al.
Journal of Chromatography. A|July 30, 2013
The evaluation of 25 chiral stationary phases and the utilization of sub-2.0μm coated polysaccharide chiral stationary phases via supercritical fluid chromatographyChris Hamman, Mengling Wong, Ignacio Aliagas, et al.
Journal of Computer-Aided Molecular Design|February 25, 2015
A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discoveryIgnacio Aliagas, Alberto Gobbi, Timothy Heffron, et al.
Journal of Cheminformatics|November 1, 2017
chemalot and chemalot_knime: Command line programs as workflow tools for drug discoveryMan-Ling Lee, Ignacio Aliagas, Jianwen A Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moietyDaniel J Burdick, James C Marsters, Ignacio Aliagas-Martin, et al.
Chemical Research in Toxicology|April 8, 2010
Formation of a quinoneimine intermediate of 4-fluoro-N-methylaniline by FMO1: carbon oxidation plus defluorinationJames P Driscoll, Ignacio Aliagas, Jennifer J Harris, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|February 14, 2013
Physicochemical and DMPK in silico models: facilitating their use by medicinal chemistsDaniel F Ortwine, Ignacio Aliagas
ACS Medicinal Chemistry Letters|June 26, 2018
Why Decreasing Lipophilicity Alone Is Often Not a Reliable Strategy for Extending IV Half-lifeFabio Broccatelli, Ignacio Aliagas, Hao Zheng
Drug Metabolism Letters|August 3, 2018
Using LC Retention Times in Organic Structure Determination: Drug Metabolite IdentificationWilliam L Fitch, Cyrus Khojasteh, Ignacio Aliagas, et al.
Journal of Computer-Aided Molecular Design|April 1, 2022
Comparison of logP and logD correction models trained with public and proprietary data setsIgnacio Aliagas, Alberto Gobbi, Man-Ling Lee, et al.
Journal of Chemical Information and Modeling|November 15, 2011
DEGAS: sharing and tracking target compound ideas with external collaboratorsMan-Ling Lee, Ignacio Aliagas, Jennafer Dotson, et al.
Journal of Chromatography. A|July 30, 2013
The evaluation of 25 chiral stationary phases and the utilization of sub-2.0μm coated polysaccharide chiral stationary phases via supercritical fluid chromatographyChris Hamman, Mengling Wong, Ignacio Aliagas, et al.
Journal of Computer-Aided Molecular Design|February 25, 2015
A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discoveryIgnacio Aliagas, Alberto Gobbi, Timothy Heffron, et al.
Journal of Cheminformatics|November 1, 2017
chemalot and chemalot_knime: Command line programs as workflow tools for drug discoveryMan-Ling Lee, Ignacio Aliagas, Jianwen A Feng, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moietyDaniel J Burdick, James C Marsters, Ignacio Aliagas-Martin, et al.
Chemical Research in Toxicology|April 8, 2010
Formation of a quinoneimine intermediate of 4-fluoro-N-methylaniline by FMO1: carbon oxidation plus defluorinationJames P Driscoll, Ignacio Aliagas, Jennifer J Harris, et al.
Pageof 3